IRIS Accounts Production v25.2.0.378 SC493832 Board of Directors 1.1.24 31.12.24 31.12.24 true false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4938322023-12-31SC4938322024-12-31SC4938322024-01-012024-12-31SC4938322022-12-31SC4938322023-01-012023-12-31SC4938322023-12-31SC493832ns15:Scotland2024-01-012024-12-31SC493832ns14:PoundSterling2024-01-012024-12-31SC493832ns10:Director12024-01-012024-12-31SC493832ns10:PrivateLimitedCompanyLtd2024-01-012024-12-31SC493832ns10:SmallEntities2024-01-012024-12-31SC493832ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-31SC493832ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-31SC493832ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-31SC493832ns10:FullAccounts2024-01-012024-12-31SC49383212024-01-012024-12-31SC493832ns10:Director22024-01-012024-12-31SC493832ns10:RegisteredOffice2024-01-012024-12-31SC493832ns5:CurrentFinancialInstruments2024-12-31SC493832ns5:CurrentFinancialInstruments2023-12-31SC493832ns5:Non-currentFinancialInstruments2024-12-31SC493832ns5:Non-currentFinancialInstruments2023-12-31SC493832ns5:ShareCapital2024-12-31SC493832ns5:ShareCapital2023-12-31SC493832ns5:RetainedEarningsAccumulatedLosses2024-12-31SC493832ns5:RetainedEarningsAccumulatedLosses2023-12-31SC493832ns5:IntangibleAssetsOtherThanGoodwill2023-12-31SC493832ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-31SC493832ns5:IntangibleAssetsOtherThanGoodwill2024-12-31SC493832ns5:IntangibleAssetsOtherThanGoodwill2023-12-31SC493832ns5:PlantMachinery2023-12-31SC493832ns5:PlantMachinery2024-01-012024-12-31SC493832ns5:PlantMachinery2024-12-31SC493832ns5:PlantMachinery2023-12-31SC493832ns5:CostValuation2023-12-31SC493832ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-31SC493832ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31
REGISTERED NUMBER: SC493832 (Scotland)













UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

UK HEALTH ENTERPRISES LTD

UK HEALTH ENTERPRISES LTD (REGISTERED NUMBER: SC493832)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 DECEMBER 2024




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


UK HEALTH ENTERPRISES LTD

COMPANY INFORMATION
for the year ended 31 DECEMBER 2024







DIRECTORS: Mrs J Dunbar
I Dunbar





REGISTERED OFFICE: Atlantic House
45 Hope Street
Glasgow
G2 6AE





REGISTERED NUMBER: SC493832 (Scotland)





ACCOUNTANTS: Thomas Barrie & Co LLP
Atlantic House
1a Cadogan Street
Glasgow
G2 6QE

UK HEALTH ENTERPRISES LTD (REGISTERED NUMBER: SC493832)

STATEMENT OF FINANCIAL POSITION
31 DECEMBER 2024

2024 2023
Notes £    £   
FIXED ASSETS
Intangible assets 4 20,676 24,113
Tangible assets 5 13,504 19,431
Investments 6 200 200
34,380 43,744

CURRENT ASSETS
Stocks 31,329 17,685
Debtors 7 143,492 120,752
Cash at bank and in hand 62,224 72,223
237,045 210,660
CREDITORS
Amounts falling due within one year 8 (157,378 ) (138,709 )
NET CURRENT ASSETS 79,667 71,951
TOTAL ASSETS LESS CURRENT
LIABILITIES

114,047

115,695

CREDITORS
Amounts falling due after more than one year 9 (5,000 ) (15,000 )

PROVISIONS FOR LIABILITIES (3,376 ) (619 )
NET ASSETS 105,671 100,076

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 105,571 99,976
SHAREHOLDERS' FUNDS 105,671 100,076

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

UK HEALTH ENTERPRISES LTD (REGISTERED NUMBER: SC493832)

STATEMENT OF FINANCIAL POSITION - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 26 September 2025 and were signed on its behalf by:





Mrs J Dunbar - Director


UK HEALTH ENTERPRISES LTD (REGISTERED NUMBER: SC493832)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 DECEMBER 2024

1. STATUTORY INFORMATION

UK Health Enterprises Ltd is a private company, limited by shares, registered in Scotland, registration number SC493832. The registered office is Atlantic House, 45 Hope Street, Glasgow, G2 6AE.

The principal activity of the company is providing health & safety solutions and training.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The presentational and functional currency of the financial statements is Pounds Sterling (£).

Significant judgements and estimates
In preparing these financial statements, the directors are required to make judgements, estimates and assumptions that affect the application of the Group’s accounting policies and the reported amounts of assets, liabilities, income and expenses. Actual results may differ from these estimates. Estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to estimates are recognised prospectively.

The following judgements and estimates have had the most significant effects on amounts recognised in the financial statements:

Plant and equipment etc
The estimates and assumptions made to determine asset lives require judgements to be made as regards useful lives and residual values. The useful lives and residual values of the company's financial assets are determined by management at the time the asset is acquired and reviewed annually for appropriateness. The lives are based on management experience with similar assets. The depreciation rates applied are outlined later in these notes.

Turnover
Turnover is measured at the fair value of consideration received or receivable, taking into account the amount of any discounts and rebates allowed by the entity, but excluding value added tax and other sales taxes.

Services
Income from services is recognised when performed, such that risks and rewards have been transferred to the end user.

Government grants
Government grants in relation to tangible fixed assets are credited to the income statement over the useful lives of the related assets, whereas those in relation to expenditure are credited when the expenditure is charged to the income statement.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of three years.

UK HEALTH ENTERPRISES LTD (REGISTERED NUMBER: SC493832)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 DECEMBER 2024

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery etc - 33% on cost, 25% on reducing balance, 20% on cost, 15% on cost and 10% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost less impairment.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
The company has financial assets and financial liabilities of a kind that qualify as basic financial instruments.

Debtors
Short term debtors are measured at transaction price, less any impairment.

Cash and cash equivalents
Cash and cash equivalents comprise cash balances, including bank overdrafts that are payable on demand and form an integral part of the company's cash management.

Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Provisions
Provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. The unwinding of the discount is recognised as finance cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


UK HEALTH ENTERPRISES LTD (REGISTERED NUMBER: SC493832)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 DECEMBER 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Short-term employee benefits
Short term employee benefits, including holiday pay, are recognised as an expense in profit and loss in the period in which they are incurred. A liability is recognised for the amount expected to be paid if the company has a present legal or constructive obligation to pay this amount as a result of past service provided by the employee, and the obligation can be estimated reliably.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 34 (2023 - 31 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 January 2024
and 31 December 2024 109,674
AMORTISATION
At 1 January 2024 85,561
Charge for year 3,437
At 31 December 2024 88,998
NET BOOK VALUE
At 31 December 2024 20,676
At 31 December 2023 24,113

UK HEALTH ENTERPRISES LTD (REGISTERED NUMBER: SC493832)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 DECEMBER 2024

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 January 2024 86,682
Additions 4,353
At 31 December 2024 91,035
DEPRECIATION
At 1 January 2024 67,251
Charge for year 10,280
At 31 December 2024 77,531
NET BOOK VALUE
At 31 December 2024 13,504
At 31 December 2023 19,431

6. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 January 2024
and 31 December 2024 200
NET BOOK VALUE
At 31 December 2024 200
At 31 December 2023 200

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 136,253 99,606
Other debtors 7,239 21,146
143,492 120,752

UK HEALTH ENTERPRISES LTD (REGISTERED NUMBER: SC493832)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 DECEMBER 2024

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 10,000 10,000
Trade creditors 52,422 41,842
Amounts owed to group undertakings 200 200
Taxation and social security 56,711 51,731
Other creditors 38,045 34,936
157,378 138,709

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 5,000 15,000

10. RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.